This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
style-scores: Archive
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BWAYNegative Net Change
earnings-surprise price-change style-scores valuation
Bright Horizons Family Solutions Inc. (BFAM) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Bright Horizons (BFAM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BFAMNegative Net Change LRNNegative Net Change
earnings-surprise price-change style-scores valuation
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CLBTNegative Net Change VLTONegative Net Change
earnings-surprise price-change style-scores valuation
Dole PLC (DOLE) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Dole (DOLE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DOLENegative Net Change
earnings-surprise price-change style-scores valuation
Sylvamo Corporation (SLVM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Sylvamo (SLVM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SLVMNegative Net Change
earnings-surprise price-change style-scores valuation
Genpact Limited (G) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Genpact (G) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
GPositive Net Change
earnings-surprise price-change style-scores valuation
The Progressive Corporation (PGR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Progressive (PGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PGRPositive Net Change WRBPositive Net Change
earnings-surprise price-change style-scores valuation
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DVANegative Net Change PNTGNegative Net Change
earnings-surprise price-change style-scores valuation
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
THCNegative Net Change UHSNegative Net Change
earnings-surprise price-change style-scores valuation
Veracyte, Inc. (VCYT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Veracyte (VCYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
VCYTNegative Net Change TMDXNegative Net Change
earnings-surprise price-change style-scores valuation
CLEAR Secure, Inc. (YOU) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Clear Secure (YOU) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
YOUNegative Net Change ALLENegative Net Change
earnings-surprise price-change style-scores valuation
Boot Barn Holdings, Inc. (BOOT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Boot Barn (BOOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BOOTNegative Net Change AEONegative Net Change
earnings-surprise price-change style-scores valuation
Clover Health Investments, Corp. (CLOV) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Clover Health Investments (CLOV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CLOVNegative Net Change
earnings-surprise price-change style-scores valuation
Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UHSNegative Net Change THCNegative Net Change
earnings-surprise price-change style-scores valuation
ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Adma Biologics (ADMA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ADMANegative Net Change EXELPositive Net Change
earnings-surprise price-change style-scores valuation
Personalis, Inc. (PSNL) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Personalis (PSNL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PSNLNegative Net Change
earnings-surprise price-change style-scores valuation
Cinemark Holdings Inc (CNK) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cinemark (CNK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CNKNegative Net Change
earnings-surprise price-change style-scores valuation
Iamgold Corporation (IAG) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Iamgold (IAG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IAGPositive Net Change AEMPositive Net Change
earnings-surprise price-change style-scores valuation
Stride, Inc. (LRN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
K12 (LRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LRNNegative Net Change LOPEPositive Net Change
earnings-surprise price-change style-scores valuation
AMNEAL PHARMACEUTICALS, INC. (AMRX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Amneal (AMRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AMRXPositive Net Change JAZZNegative Net Change
earnings-surprise price-change style-scores valuation
CareDx, Inc. (CDNA) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
CareDx (CDNA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CDNANegative Net Change SHCNegative Net Change
earnings-surprise price-change style-scores valuation
EZCORP, Inc. (EZPW) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Ezcorp (EZPW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EZPWPositive Net Change ENVANegative Net Change
earnings-surprise price-change style-scores valuation
Parsons Corporation (PSN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Parsons (PSN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PSNPositive Net Change VSTANegative Net Change
earnings-surprise price-change style-scores valuation
Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Exagen (XGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
XGNNegative Net Change
earnings-surprise price-change style-scores valuation
Cabot Corporation (CBT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CBTNegative Net Change
earnings-surprise price-change style-scores valuation